Provided by Tiger Trade Technology Pte. Ltd.

Sol-Gel Technologies

75.40
+4.005.60%
Volume:14.56K
Turnover:1.05M
Market Cap:246.48M
PE:-34.28
High:77.20
Open:71.07
Low:70.90
Close:71.40
52wk High:97.97
52wk Low:4.11
Shares:3.27M
Float Shares:709.20K
Volume Ratio:0.48
T/O Rate:2.05%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.1993
EPS(LYR):-2.1993
ROE:-23.72%
ROA:-14.43%
PB:10.81
PE(LYR):-34.28

Loading ...

Company Profile

Company Name:
Sol-Gel Technologies
Exchange:
NASDAQ
Establishment Date:
1997
Employees:
28
Office Location:
7 Golda Meir Street,Weizmann Science Park,Ness Ziona,Israel
Zip Code:
7403650
Fax:
- -
Introduction:
Sol-Gel Technologies Ltd., together with its subsidiary Sol-Gel Technologies Inc., develops topical dermatological drugs for patients with severe skin conditions in Israel. The company offers Twyneo, a once-daily, non-antibiotic topical cream for the treatment of acne vulgaris; and Epsolay, a once-daily topical cream for the treatment of papulopustular (subtype II) rosacea. It also develops SGT-610 that is in Phase 3 clinical trials for the treatment of Gorlin Syndrome; and SGT-210, which has completed Phase I clinical trial, to treat rare hyperkeratinization disorders, such as Darier, PC, PPK, Olmsted, etc. In addition, the company is also involved in the development of generic topical dermatological drug products. It has collaboration with Padagis Israel Pharmaceuticals Ltd; and license agreements with Galderma Holding SA and Searchlight Pharma Inc. Sol-Gel Technologies Ltd. was incorporated in 1997 and is headquartered in Ness Ziona, Israel.

Directors

Name
Position
Moshe Arkin
Executive Chairman of the Board and interim Chief Executive Officer
Ran Gottfried
Lead Independent Director
Sharon Kochan
Independent Director
Yuval Yanai
Independent Director
Hani Lerman
Director
Itai Arkin
Director

Shareholders

Name
Position
Moshe Arkin
Executive Chairman of the Board and interim Chief Executive Officer
Itzik Yosef
Chief Operating Officer
Eyal Ben Or
Chief Financial Officer
Michael Glezin
Chief Business Officer
Ofer Toledano
Vice President Research and Development
Ofra Levy Hacham
Vice President Clinical, Regulatory Affairs and Quality